Most people will continue to need lifelong thyroid hormone replacement, although the dose may change over time under medical supervision
%20increase%20testosterone%20levels%20in%20women%3F)

Methodology and Sources This analysis is based on publicly available sources as of December 26, 2025: FDA communications: Compounding safety alerts, prescribing information, and regulatory guidance Novo Nordisk announcements: Wegovy pill approval, OASIS 4 trial results, pricing disclosures Independent reporting and primary sources: ABC News coverage and Novo Nordisk's announcement on December 22, 2025 FDA oral Wegovy approval MEDVi terms and disclosures: Platform structure, pricing, and regulatory disclaimers Key Sources Cited: ABC News: "FDA approves Wegovy pill for weight loss" (December 22, 2025) Novo Nordisk: Official press release on FDA approval and OASIS 4 trial data (December 22, 2025) FDA Safety Communications: 2024-2025 alerts on compounded semaglutide dosing errors What this analysis does not include: Medical advice, treatment recommendations, or product endorsements

The normalized relationship with food, the absence of constant food thoughts, and the confidence that comes with physical changes create a foundation for sustained lifestyle changes that support long-term maintenance